Sleep duration and insulin resistance in individuals without type 2 diabetes: The PPP-Botnia Study

References

• International Diabetes Foundation. IDF Diabetes Atlas, 5th ed. Brussels, Belgium: International Diabetes Foundation; 2011.
   Google Scholar
• Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.
   PubMed Web of Science ®Google Scholar
• Roth T, Coulouvrat C, Hajak G, Lakoma MD, Sampson NA, Shahly V, et al. Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey. Biol Psychiatry. 2011;69:592–600.
   PubMed Web of Science ®Google Scholar
• Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care. 2006;29: 657–61.
   PubMed Web of Science ®Google Scholar
• Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, et al. Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep. 2007;30:1667–73.
   PubMed Web of Science ®Google Scholar
• Gottlieb DJ, Punjabi NM, Newman AB, Resnick HE, Redline S, Baldwin CM, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med. 2005;165:863–7.
   PubMed Web of Science ®Google Scholar
• Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 2003;26:380–4.
   PubMed Web of Science ®Google Scholar
• Chao CY, Wu JS, Yang YC, Shih CC, Wang RH, Lu FH, et al. Sleep duration is a potential risk factor for newly diagnosed type 2 diabetes mellitus. Metabolism. 2011;60:799–804.
   PubMed Web of Science ®Google Scholar
• Mallon L, Broman JE, Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care. 2005;28:2762–7.
   PubMed Web of Science ®Google Scholar
• Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33:414–20.
   PubMed Web of Science ®Google Scholar
• Donga E, van Dijk M, van Dijk JG, Biermasz NR, Lammers GJ, van Kralingen KW, et al. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab. 2010;95:2963–8.
   PubMed Web of Science ®Google Scholar
• Buxton OM, Pavlova M, Reid EW, Wang W, Simonson DC, Adler GK. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes. 2010;59:2126–33.
   PubMed Web of Science ®Google Scholar
• Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435–9.
   PubMed Web of Science ®Google Scholar
• Rafalson L, Donahue RP, Stranges S, Lamonte MJ, Dmochowski J, Dorn J, et al. Short sleep duration is associated with the development of impaired fasting glucose: the Western New York Health Study. Ann Epidemiol. 2010;20:883–9.
   PubMed Web of Science ®Google Scholar
• Liu R, Zee PC, Chervin RD, Arguelles LM, Birne J, Zhang S, et al. Short sleep duration is associated with insulin resistance independent of adiposity in Chinese adult twins. Sleep Med. 2011;12:914–19.
   PubMed Web of Science ®Google Scholar
• Pyykkönen AJ, Isomaa B, Pesonen AK, Eriksson JG, Groop L, Tuomi T, et al. Subjective sleep complaints are associated with insulin resistance in individuals without diabetes: the PPP-Botnia Study. Diabetes Care. 2012;35:2271–8.
   PubMed Web of Science ®Google Scholar
• Pyykkönen AJ, Räikkönen K, Tuomi T, Eriksson JG, Groop L, Isomaa B. Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: results from the PPP-Botnia Study. Ann Med. 2012;44:279–88.
   PubMed Web of Science ®Google Scholar
• Pyykkönen AJ, Räikkönen K, Tuomi T, Eriksson JG, Groop L, Isomaa B. Depressive symptoms, antidepressant medication use, and insulin resistance: the PPP-Botnia Study. Diabetes Care. 2011; 34:2545–7.
   PubMed Web of Science ®Google Scholar
• Pyykkönen AJ, Räikkonen K, Tuomi T, Eriksson JG, Groop L, Isomaa B. Stressful life events and the metabolic syndrome: the prevalence, prediction and prevention of diabetes (PPP)-Botnia Study. Diabetes Care. 2010;33:378–84.
   PubMed Web of Science ®Google Scholar
• Isomaa B, Forsen B, Lahti K, Holmstrom N, Waden J, Matintupa O, et al. A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study. Diabetologia. 2010;53:1709–13.
   PubMed Web of Science ®Google Scholar
• Silva N, Atlantis E, Ismail K. A review of the association between depression and insulin resistance: pitfalls of secondary analyses or a promising new approach to prevention of type 2 diabetes?Curr Psychiatry Rep. 2012;14:8–14.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–19.
   PubMed Web of Science ®Google Scholar
• Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 1987;79:790–800.
   PubMed Web of Science ®Google Scholar
• Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol. 2000;151:190–8.
   PubMed Web of Science ®Google Scholar
• Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes. 2002;51 (Suppl 1):S212–20.
   Google Scholar
• Partinen M, Gislason T. Basic Nordic Sleep Questionnaire (BNSQ): a quantitated measure of subjective sleep complaints. J Sleep Res. 1995;4(S1):150–5.
   PubMedGoogle Scholar
• Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996;67:588–97.
   PubMed Web of Science ®Google Scholar
• Spielberger C, Gorsuch R, Lushene R, Vagg P, Jacobs G. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
   Google Scholar
• Salonen JT, Lakka TA. Assessment of physical activity in population studies–validity and consistency of the methods in the Kuopio Ischemic Heart Disease Risk Factor Study. Scand J Sports Sci. 1987;9:89–95.
   Google Scholar
• Pesonen AK, Kajantie E, Heinonen K, Pyhala R, Lahti J, Jones A, et al. Sex-specific associations between sleep problems and hypothalamic-pituitary-adrenocortical axis activity in children. Psychoneuroendocrinology. 2012;37:238–48.
   PubMed Web of Science ®Google Scholar
• Paavonen EJ, Strang-Karlsson S, Räikkönen K, Heinonen K, Pesonen AK, Hovi P, et al. Very low birth weight increases risk for sleep-disordered breathing in young adulthood: the Helsinki Study of Very Low Birth Weight Adults. Pediatrics. 2007;120:778–84.
   PubMed Web of Science ®Google Scholar
• Räikkönen K, Matthews KA, Kuller LH. Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabetes Care. 2007;30:872–7.
   PubMed Web of Science ®Google Scholar
• Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ. Self-reported and measured sleep duration: how similar are they? Epidemiology. 2008;19:838–45.
   PubMed Web of Science ®Google Scholar